Xuanwu Hospital, Beijing

This early-stage study is testing whether tiny particles derived from umbilical cord cells, injected into the spinal fluid, are safe for people with syringomyelia. The trial will enroll 18 adults who still have spinal cord symptoms despite previous treatment or natural improvemen…

This small study is testing whether a daily pill called everolimus can safely shrink abnormal blood vessel growths (vascular malformations) in adults. Ten participants who aren't good candidates for surgery will take the medication and have regular MRI scans to see if their lesio…

This study is testing whether adding a special near-infrared light therapy to the approved Alzheimer's drug lecanemab is safe and more effective at controlling the disease. It will involve 20 people with mild Alzheimer's. For 16 weeks, half will get the real light therapy with th…

This small, early-stage study is testing whether adding the drug everolimus to a person's current anti-seizure medications can help reduce seizure frequency in adults with focal epilepsy that doesn't respond well to standard drugs. The idea is based on research suggesting everoli…

This study tests whether performing skull removal surgery very early after a severe stroke can prevent dangerous brain swelling and improve survival. It compares early surgery against standard care in 380 patients who have had a major stroke and are at high risk for brain swellin…

This trial is testing whether a new, less invasive surgery performed soon after a severe brain bleed can help people recover better. It will compare this early surgery to the current best medical care in 750 patients. The main goal is to see if patients who get the surgery have b…

This study is testing whether giving a clot-busting medication called Tenecteplase to stroke patients at their first hospital, before transferring them to a specialized center for advanced treatment, leads to better recovery. The trial involves 572 adults who have had a major str…

This study is testing if giving a clot-busting drug (tenecteplase) to stroke patients before they are transferred to a specialized hospital for a clot-removal procedure leads to better recovery. It focuses on patients with a severe type of stroke caused by a blockage in a major b…

This study is testing if adding a drug called batroxobin to standard blood thinners helps clear dangerous clots in the brain's veins more quickly. It will involve 72 adults who recently developed this condition. Researchers will compare recovery and clot clearance between those g…

This early-stage study is testing whether tiny particles called exosomes, collected from human stem cells, can help the brain recover after a sudden stroke caused by a blocked blood vessel. Researchers will give these particles through an IV to a small group of patients to first …

This study is testing whether a structured physical therapy and education program can slow down or prevent new wear and tear in the spine next to where a fusion surgery was performed. It involves 212 frail adults aged 75 and older who are having a short lumbar fusion. The goal is…

This small, early-stage study is testing whether a drug called galcanezumab, currently used for migraines, can help people with mild-to-moderate Alzheimer's disease. Ten participants will receive injections of the drug every four weeks for six months. Researchers will measure cha…

This large Phase 3 trial is testing which of two clot-busting drugs works better for people having a major stroke caused by a large blocked artery. About 850 patients will be randomly assigned to receive either the standard drug (alteplase) or a newer alternative (tenecteplase) w…

This study is testing if using a special balloon catheter during emergency stroke surgery helps restore blood flow more effectively on the first try. It will involve 364 adults who have had a stroke caused by a major blockage in a specific neck artery. Researchers will compare th…

This study is testing a new type of MRI scan to see if it can better predict who is most at risk of having a stroke due to narrowed brain arteries. It will follow 400 patients in China for one year while they receive standard stroke-prevention medications. The goal is to see if t…

This study aims to see if a more detailed type of CT scan can more accurately identify the specific blocked artery in patients with a 'medium vessel' stroke. Researchers will compare the new scan method to standard scans in about 622 stroke patients. The goal is to improve the sp…

This study aims to create a better way to spot early signs of Alzheimer's disease. It will test 6,000 adults aged 50+ using a two-step approach: first, a quick digital app to check memory and thinking, and second, a blood test to look for Alzheimer's-related proteins. The goal is…

This study is testing whether a gentle, non-invasive ultrasound treatment aimed at a specific brain area can improve thinking and memory problems in people with long COVID 'brain fog'. Researchers in Beijing will give 40 participants either the real ultrasound treatment or a sham…

This study is testing if a common pain medication (oxycodone/acetaminophen) is safe and effective for treating chronic pain in people who have Alzheimer's disease. It will involve 10 participants who will take the medication daily for 12 weeks. Researchers will track changes in p…

This study looks back at medical records to learn about stroke patients who received a standard clot-busting drug much later than the usual recommended time window. Researchers will analyze data from about 2,600 patients to see how well they recovered and if the treatment was saf…

This study aims to understand how different types of surgery affect recovery for people who have had a brain bleed. Researchers will follow 500 patients after their operations to track their physical function and quality of life over time. The goal is to gather detailed informati…

This study aims to better understand how narrowed arteries in the neck affect blood flow and energy use in the brain. Researchers will use combined PET and MRI scans on 200 patients with this condition to look for patterns and connections with their symptoms. The goal is to find …

This large observational study aims to understand a serious complication called delayed ischemic neurological deficit (DIND) that can happen after a brain aneurysm bleed. It will follow 10,000 patients for a year to see how often DIND occurs, track how different hospitals diagnos…